Identification of clickable HIV-1 capsid-targeting probes for viral replication inhibition

Copyright © 2024 Elsevier Ltd. All rights reserved..

Of the targets for HIV-1 therapeutics, the capsid core is a relatively unexploited but alluring drug target due to its indispensable roles throughout virus replication. Because of this, we aimed to identify "clickable" covalent modifiers of the HIV-1 capsid protein (CA) for future functionalization. We screened a library of fluorosulfate compounds that can undergo sulfur(VI) fluoride exchange (SuFEx) reactions, and five compounds were identified as hits. These molecules were further characterized for antiviral effects. Several compounds impacted in vitro capsid assembly. One compound, BBS-103, covalently bound CA via a SuFEx reaction to Tyr145 and had antiviral activity in cell-based assays by perturbing virus production, but not uncoating. The covalent binding of compounds that target the HIV-1 capsid could aid in the future design of antiretroviral drugs or chemical probes that will help study aspects of HIV-1 replication.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

Cell chemical biology - 31(2024), 3 vom: 21. März, Seite 477-486.e7

Sprache:

Englisch

Beteiligte Personen:

McFadden, William M [VerfasserIn]
Casey-Moore, Mary C [VerfasserIn]
Bare, Grant A L [VerfasserIn]
Kirby, Karen A [VerfasserIn]
Wen, Xin [VerfasserIn]
Li, Gencheng [VerfasserIn]
Wang, Hua [VerfasserIn]
Slack, Ryan L [VerfasserIn]
Snyder, Alexa A [VerfasserIn]
Lorson, Zachary C [VerfasserIn]
Kaufman, Isabella L [VerfasserIn]
Cilento, Maria E [VerfasserIn]
Tedbury, Philip R [VerfasserIn]
Gembicky, Milan [VerfasserIn]
Olson, Arthur J [VerfasserIn]
Torbett, Bruce E [VerfasserIn]
Sharpless, K Barry [VerfasserIn]
Sarafianos, Stefan G [VerfasserIn]

Links:

Volltext

Themen:

Antiviral Agents
Antiviral screen
Capsid
Capsid Proteins
Capsid-targeting compound
Click chemistry
HIV-1
Journal Article
SuFEx

Anmerkungen:

Date Completed 25.03.2024

Date Revised 13.04.2024

published: Print

Citation Status MEDLINE

doi:

10.1016/j.chembiol.2024.02.012

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370083148